Building Breakthroughs Together
Our trusted partners drive innovation and amplify our impact. Together, we shape the future of cancer treatment.
Our Valued Partners in Innovation
Gustave Roussy
Gustave Roussy supports PepKon by providing expertise in oncology research for the development of peptide therapies targeting various cancer cell lines with high unmet medical needs. This partnership helps advance innovative treatments for challenging cancer types.
EIT Catapult
PepKon is currently a semi-finalist in the EIT Health Catapult program, which provides access to an extensive international network and specialized mentorship. This opportunity enhances our potential to advance innovative cancer therapies.
Sorbonne University
Pepkon collaborates with DRUGLab, a Sorbonne University research lab led by Prof. Karoyan. Specializing in therapeutic peptides, DRUGLab supports the design and preclinical evaluation of our drug candidates, reinforcing Pepkon's translational approach.
VCLS
Voisin Consulting Life Sciences (VCLS) assists PepKon with a tailored EU regulatory strategy and roadmap, ensuring compliance, streamlined submissions, and efficient market entry for therapeutic peptides.
BPI France
PepKon has received substantial support from Bpifrance, including the OC French Tech Seed, Innov’up Leader PIA, and Deeptech Development programs, and was honored as a laureate of the prestigious I-Lab competition.
ICOSA
ICOSA provides strategic expertise in intellectual property management, supporting PepKon in the filing of new peptide patents while ensuring strong protection of its innovations.
INITS
INITS supports Pepkon in its CMC activities to structure and optimize the development of its drug candidate. With its expertise in drug manufacturing and regulatory compliance, INITS contributes to establishing the industrial strategy.
ILIFE Consulting
ILife Consulting assists Pepkon in structuring and anticipating its clinical development, ensuring a smooth transition to first-in-human studies through optimized trial design and regulatory strategy.
Agoranov
PepKon is proud to have been a member of the Agoranov incubator. This program provided valuable support for growth and development through strategic mentorship, networking opportunities, and a dynamic community of entrepreneurs.